clinicaltrialsarena1h
Arcturus Therapeutics launches Phase I Avian Influenza trials in US
The announcement follows just days after the US Centres for Disease Control confirmed its first death from Avian Influenza.
clinicaltrialsarena1h
IO Biotech enrols all subjects in Phase II trial of cancer combination therapy
IO Biotech has finished enrolling subjects in a Phase II trial of IO102-IO103 in conjunction with MSD's KEYTRUDA (pembrolizumab).
clinicaltrialsarena4h
IMG Biosciences enacts massive lay-offs after Phase I trial failure
Following the negative Phase I trial outcome for its autoimmune disease treatment, the company is enacting lay-offs, cutting 73% of jobs.
clinicaltrialsarena5h
Alentis Therapeutics reports positive results from organ fibrosis treatment trials
Alentis Therapeutics has reported positive topline outcomes from two clinical trials of lixudebart (ALE.F02) for reversing organ fibrosis.
clinicaltrialsarena7h
Sanofi reports positive results from trial of multiple myeloma drug candidate
Sanofi has reported results from its Phase III IRAKLIA trial of Sarclisa (isatuximab) as a potential treatment for multiple myeloma (MM).
clinicaltrialsarena23h
South Korean study shows high prevalence of smoking among HIV patients
In South Korea, public health authorities have expressed concern about smoking in HIV patients due to the habit’s high societal acceptance.
clinicaltrialsarena23h
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...